No Data
No Data
Kang Peng Technology (688602.SH) reported first-quarter results, net profit of 19.1751 million yuan, a year-on-year decrease of 10.89%
According to Zhitong Finance App News, Kang Peng Technology (688602.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 169 million yuan, a year-on-year decrease of 23.02%; net profit attributable to shareholders of listed companies was 19.1751 million yuan, a year-on-year decrease of 10.89%; non-recurring net profit and loss attributable to shareholders of listed companies deducted 15.3814 million yuan; basic earnings per share were 0.04 yuan/share.
The A-share diet pill concept fluctuated higher. Kanghui Pharmaceutical went up and down, Kangpeng Technology rose more than 6%, and Nanowei Technology, Haoyuan Pharmaceutical, Medici, and Prius followed suit.
The A-share diet pill concept fluctuated higher. Kanghui Pharmaceutical went up and down, Kangpeng Technology rose more than 6%, and Nanowei Technology, Haoyuan Pharmaceutical, Medici, and Prius followed suit.
Kang Peng Technology (688602.SH): LiFSi can be used in semi-solid state batteries
Gelonghui, March 18 | Kang Peng Technology (688602.SH) said on the investor interactive platform that (1) According to the currently known technology path, LiFSi can be used for semi-solid state batteries. (2) Product market prices are affected by various factors such as changes in market supply and demand. Currently, market competition is relatively intense.
Kang Peng Technology (688602.SH): 6.444,500 restricted shares will be listed and circulated from January 22
Kang Peng Technology (688602.SH) issued an announcement regarding the initial public offering of restricted shares for offline placement. This time...
Kang Peng Technology (688602): One of the leaders in the domestic fluorine-containing fine chemical industry is optimistic about the company's medium- to long-term growth
The allocation of two major sectors, new materials, pharmaceuticals, and pesticide chemicals establishes a stable revenue stream in diversified downstream application fields. Kangpeng Technology is a high-tech enterprise engaged in R&D, production and sales of fluorine-containing fine chemicals. The company uses specialty chemicals containing fluorine
Kangpeng Technology (688602.SH): The company has technical reserves related to PEEK key monomers
Gelonghui, December 21|Kang Peng Technology (688602.SH) said on the investor interactive platform on December 21 that the company has technical reserves related to key PEEK monomers.
No Data